Lunai Bioworks LNAI Income Statement (2011-2026)

NASDAQ LNAI
$2.20 -0.02 (-0.90%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.02M
Cost of Revenue (Quarter)
Gross Profit (Quarter)
0.02M
Operating items
Research & Development (Quarter)
12.15M3.06M2.34M1.21M1.77M2.61M0.33M0.24M0.99M0.57M0.62M1.09M0.43M0.39M0.16M-0.09M0.08M0.02M0.05M0.02M
Selling, General & Administrative (Quarter)
2.01M4.42M3.96M2.79M3.16M4.56M4.01M3.80M2.95M8.29M3.62M7.65M5.00M5.30M4.35M4.22M4.00M2.41M1.77M1.42M
Restructuring Costs (Quarter)
-9.04M0.05M0.19M4.03M4.35M4.22M4.00M2.41M1.77M1.42M
Other Operating Expenses (Quarter)
9.07M-0.02M-0.16M-4.00M93.28M0.03M0.03M0.03M18.99M0.03M0.03M42.64M11.67M47.65M-4.32M-4.19M118.84M-1.54M-1.75M-1.41M
Operating Expenses (Quarter)
14.18M7.50M6.33M4.03M98.21M7.19M4.37M4.06M22.93M8.88M4.27M51.38M17.10M53.34M4.55M4.16M126.92M3.31M1.82M1.45M
Operating Income (Quarter)
-14.18M-7.50M-6.33M-4.03M-98.21M-7.19M-4.37M-4.06M-22.93M-8.88M-4.27M-51.38M-17.10M-53.34M-4.55M-4.16M-126.92M-3.31M-1.82M-1.48M
EBIT (Quarter)
-14.18M-7.50M-6.33M-4.03M-98.21M-7.19M-4.37M-4.06M-22.93M-8.88M-4.27M-51.38M-17.10M-53.34M-4.55M-4.16M-126.92M-3.31M-1.82M-1.48M
Non-operating items
Non Operating Investment Income (Quarter)
0.21M
Interest & Investment Income (Quarter)
0.00M0.01M0.01M0.01M0.10M0.01M0.00M0.01M0.13M
Other Non Operating Income (Quarter)
-124.009.00-0.42M0.42M-0.12M-1.30M72.00-72.000.03M-6.36M-0.02M
Non Operating Income (Quarter)
-3.18M-2.91M-0.25M-2.17M7.97M-0.51M-0.09M-0.14M-0.26M-0.29M-0.26M-7.61M1.37M9.13M-2.71M4.35M0.19M6.13M0.02M-1.14M
Net income details
EBT (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.73M-16.37M-53.46M-4.65M-4.35M-126.41M-3.43M-1.94M-1.59M
Tax Provisions (Quarter)
-475.0034.00
Profit After Tax (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.26M-7.70M-4.46M-4.33M-23.20M-9.18M-4.53M-58.99M-15.73M-44.21M-7.25M0.19M-126.73M2.82M-1.80M-2.57M
Income from Continuing Operations (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.73M-16.37M-53.46M-4.65M-4.35M-126.41M-3.43M-1.94M-1.59M
Consolidated Net Income (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.73M-16.37M-53.46M-4.65M-4.35M-126.41M-3.43M-1.94M-1.59M
Income towards Parent Company (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.73M-16.37M-53.46M-4.65M-4.35M-126.41M-3.43M-1.94M-1.59M
Net Income towards Common Stockholders (Quarter)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.73M-16.37M-53.46M-4.65M-4.35M-126.41M-3.43M-1.94M-1.59M
Additional items
EPS (Basic) (Quarter)
-29.45-15.95-10.07-9.42-137.43-11.18-6.42-6.19-32.98-11.38-5.52-38.50-13.60-27.32-2.30-2.14-61.26-1.22-0.66-0.51
EPS (Diluted) (Quarter)
-145.70-87.37-55.24-52.04-137.43-11.18-6.42-6.19-32.98-11.38-5.52-38.50-13.60-27.32-2.30-2.12-61.26-1.22-0.66-0.51
Shares Outstanding (Quarter)
0.59M0.65M0.65M0.66M0.66M0.69M0.69M0.70M0.70M0.81M0.82M1.34M1.20M1.96M2.02M2.03M2.06M2.82M2.94M3.12M
Shares Outstanding (Diluted) (Quarter)
0.12M0.12M0.12M0.12M0.66M0.69M0.69M0.70M0.70M0.81M0.82M1.34M1.20M1.96M2.02M2.05M2.06M2.82M2.94M3.12M
Shares Outstanding (Entity) (Quarter)
0.65M0.65M0.66M0.66M0.66M0.69M0.70M0.72M0.80M0.82M0.84M1.34M1.20M1.97M2.03M2.03M2.22M2.90M3.02M3.12M
EBITDA (Quarter)
-14.18M-7.50M-6.33M-4.03M-98.21M-7.19M-4.37M-4.06M-22.93M-8.88M-4.27M-51.38M-17.10M-53.34M-4.55M-4.16M-126.92M-3.31M-1.82M-1.48M
Interest Expenses (Quarter)
-0.19M0.09M0.09M0.10M-0.20M0.10M0.10M0.12M0.13M0.26M0.27M0.35M-0.74M0.25M0.10M0.19M-0.51M0.12M0.12M0.11M
Tax Rate (Quarter)
0.00%0.00%